This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción EBAC
European Biotech Acquisition Corp. does not have significant operations.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de European Biotech Acquisition Corp.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$11.19 |
| 52 Week High | US$14.10 |
| 52 Week Low | US$9.28 |
| Beta | 0 |
| 1 Month Change | 10.19% |
| 3 Month Change | 11.79% |
| 1 Year Change | 14.89% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | n/a |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| EBAC | US Capital Markets | Mercado US | |
|---|---|---|---|
| 7D | 4.1% | -0.7% | -3.2% |
| 1Y | 14.9% | 23.2% | 19.3% |
Rentabilidad vs. Industria: EBAC exceeded the US Capital Markets industry which returned -8.1% over the past year.
Rentabilidad vs. Mercado: EBAC exceeded the US Market which returned -10.9% over the past year.
Volatilidad de los precios
| EBAC volatility | |
|---|---|
| EBAC Average Weekly Movement | 7.6% |
| Capital Markets Industry Average Movement | 3.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: EBAC has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: EBAC's weekly volatility (8%) has been stable over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2021 | n/a | Eduardo Bravo de Araoz | www.lspvc.com/ebac |
Resumen de fundamentos de European Biotech Acquisition Corp.
| Estadísticas fundamentales de EBAC | |
|---|---|
| Capitalización bursátil | US$183.50m |
| Beneficios(TTM) | US$860.48k |
| Ingresos (TTM) | n/a |
213.3x
Ratio precio-beneficio (PE)0.0x
Ratio precio-ventas (PS)¿Está EBAC sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de EBAC | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$0 |
| Otros gastos | -US$860.48k |
| Beneficios | US$860.48k |
Últimos beneficios comunicados
Sep 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.052 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado EBAC a largo plazo?
Ver rendimiento histórico y comparativa